Detalhe da pesquisa
1.
Proton Pump Inhibitors Reduce Pancreatic Adenocarcinoma Progression by Selectively Targeting H+, K+-ATPases in Pancreatic Cancer and Stellate Cells.
Cancers (Basel)
; 12(3)2020 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32164284